Compare CDE & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDE | BIO |
|---|---|---|
| Founded | 1928 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5B | 8.2B |
| IPO Year | N/A | N/A |
| Metric | CDE | BIO |
|---|---|---|
| Price | $15.90 | $317.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $16.33 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 16.7M | 164.7K |
| Earning Date | 10-29-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | $1,700,723,000.00 | ★ $2,557,500,000.00 |
| Revenue This Year | $95.35 | $1.77 |
| Revenue Next Year | $35.11 | $2.30 |
| P/E Ratio | $21.49 | ★ N/A |
| Revenue Growth | ★ 68.28 | N/A |
| 52 Week Low | $4.58 | $211.43 |
| 52 Week High | $23.62 | $373.69 |
| Indicator | CDE | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 49.13 | 50.96 |
| Support Level | $15.65 | $311.81 |
| Resistance Level | $17.88 | $328.07 |
| Average True Range (ATR) | 0.85 | 10.25 |
| MACD | 0.25 | -0.18 |
| Stochastic Oscillator | 54.16 | 55.82 |
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.